CytRx Announces Partial Clinical Hold On Main Drug' Big Buying Opportunity For Investors
Article By:
Terry Chrisomalis
Read
Tuesday, November 18, 2014 2:36 PM EDT
Aldoxorubicin receives a partial clinical hold from the FDA.
In this article: CYTR
Medtronic Posts In Line Earnings, Revenues Beat In Q2
Article By:
Zacks Investment Research
Read
Tuesday, November 18, 2014 1:45 PM EDT
The company’s reported net income of $828 million or 83 cents a share were down 8.2% and 6.7%, respectively, on a year-over-year basis.
In this article: MDT
9 Insiders Purchase Shares Of Neptune On Open Market
Article By:
LastFinancier
Read
Tuesday, November 18, 2014 9:30 AM EDT
9 insiders purchased shares of Neptune in the open market during the past week, including the Company’s interim CEO and new Chairman. With activist actions underway, can Neptune stock return to prior levels?
In this article: NEPT
One Reason Why Sickcare Is Outrageously Expensive: Needless Scans/Tests
Article By:
Charles Hugh Smith
Read
Tuesday, November 18, 2014 5:26 AM EDT
Add easy profits from needless tests to defensive medicine and no cost controls or real competition, and we have the perfect formula for waste, fraud, profiteering, bad medicine and dysfunctional, unaffordable healthcare.
Work Hard And Invest In The Future: Financial Review
Article By:
Marvin R Clark
Read
Monday, November 17, 2014 8:18 PM EDT
If you thought the S&P’s furious 11% rally has been a sight to behold, you clearly weren’t paying attention to the soaring planes, trains and trucks.
Celldex Therapeutics Surges 30% After Positive Phase 2 Data In Brain Cancer
Article By:
Terry Chrisomalis
Read
Monday, November 17, 2014 5:41 PM EDT
Positive results in an interim phase 2 analysis of rindopepimut show increased survival.
In this article: CLDX
Actavis Purchase Of Allergan Makes It A "$100 Billion Merger Monday"
Article By:
Tyler Durden
Read
Monday, November 17, 2014 12:46 PM EDT
Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock.
View From The Hill: Deflation Shadows Bulls With Disequilibrium In Capital Markets
Article By:
Hillbent
Read
Sunday, November 16, 2014 6:48 PM EDT
Deflation is casting a larger shadow over the U.S. equity bull market and I believe that the Fed may be forced to defer raising rates if the U.S. Dollar continues its upward trajectory while weaker G-8 members (Japan, China, and Europe) maintain highly accommodative policies.
Make Stock Picking A Breeze With ROIC
Article By:
David Trainer
Read
Wednesday, November 12, 2014 7:49 PM EDT
Return on Invested Capital “ROIC” is the most dependable indicator to have in your investor toolbox.
Achillion Pharmaceuticals Continues To Impress With Hepatitis C Results In A Combination Study
Article By:
Terry Chrisomalis
Read
Tuesday, November 11, 2014 10:55 AM EDT
ACH-3102 showed 100% Hepatitis C virus clearance in combination with Gilead's sofosbuvir.
Dendreon Files For Bankruptcy, Stock Tanks
Article By:
Terry Chrisomalis
Read
Monday, November 10, 2014 6:47 PM EDT
Dendreon files for Chapter 11 bankruptcy after disappointing sales for Provenge
U.S. Stocks Switched Between Small Gains And Losses
Article By:
BioMedReports
Read
Friday, November 7, 2014 4:36 PM EDT
With the main benchmarks hovering near record levels in the wake of a solid jobs report, a key payrolls data showed the economy added 214,000 jobs in October, while the unemployment rate ticked down to 5.8% — a broadly positive reading.